TGFB1 and neoplasm: It was demonstrated that the treatment with those CSV-binding IL12 T cells, thanks to their interactions with CSV+ tumor cells, augmented interferon γ (TNFγ) production, while inhibiting transforming growth factor β (TGFβ) secretion and stimulating FAS-mediated apoptosis in abundant CAFs.